mybikeisorange that is okay with what you are saying. However Dr. Pierce's comments at presentations is very bullish regarding the Combo as Melanoma P2B. It is unprecedented that the FDA following $ONCS P1/2A melanoma has suddenly and unexpectedly allowing the Combo to take place as P2B.